Category: Blood Cancer

Thousands ‘Light the Night’ at Angel Stadium For Blood Cancer Research

ANAHEIM, Calif.—Thousands turned out to Angel Stadium on Nov. 17 to support fundraising efforts to end blood cancer through The Leukemia and Lymphoma Society, a New York-based nonprofit dedicated to fighting the disease across the world. The organization’s Light the Night event was hosted in the stadium’s parking lot, the area was zoned off to…


HK Develops Precision Cure to Help Children with Blood Cancer Prolong Life

Children with acute myeloid leukemia (AML) who develop drug resistance generally lack treatment options and are deemed incurable. Recently, The CUHK’s HK-HOPE developed a method to obtain the sensitivity of a patient’s cancer cells to a basket of targeted drugs within three days. In combination with genomic analyses, AML patients are matched with the most…


Pfizer to Buy Canadian Drug Developer Trillium in $2.26 Billion Deal

Pfizer has announced plans to acquire Canadian drug developer Trillium Therapeutics Inc. in a $2.26 billion deal meant to boost Pfizer’s arsenal of blood cancer therapies. Under the deal, announced in an Aug. 23 press release, Pfizer will buy all outstanding Trillium shares for $18.50 apiece, representing a 118 percent premium on the stock’s 60-day…